Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection
Kirsten E. Lyke, Andrew S. Ishizuka, Andrea A. Berry, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 10, pp. 2711-2716
Open Access | Times Cited: 236

Showing 1-25 of 236 citing articles:

Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
Benjamin Mordmüller, Güzin Surat, Heimo Lagler, et al.
Nature (2017) Vol. 542, Iss. 7642, pp. 445-449
Open Access | Times Cited: 372
RTS,S/AS01 vaccine (Mosquirix™): an overview
Matthew B. Laurens
Human Vaccines & Immunotherapeutics (2019) Vol. 16, Iss. 3, pp. 480-489
Open Access | Times Cited: 370
Malaria Vaccines: Recent Advances and New Horizons
Simon J. Draper, Brandon K. Sack, C. Richter King, et al.
Cell Host & Microbe (2018) Vol. 24, Iss. 1, pp. 43-56
Open Access | Times Cited: 299
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite
Neville K. Kisalu, Azza H. Idris, Connor Weidle, et al.
Nature Medicine (2018) Vol. 24, Iss. 4, pp. 408-416
Open Access | Times Cited: 270
Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans
Henry J. Sutton, Racheal Aye, Azza H. Idris, et al.
Cell Reports (2021) Vol. 34, Iss. 6, pp. 108684-108684
Open Access | Times Cited: 183
Challenges and strategies for developing efficacious and long-lasting malaria vaccines
James G. Beeson, Liriye Kurtovic, Carlota Dobaño, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 474
Open Access | Times Cited: 181
Malaria vaccines: the 60-year journey of hope and final success—lessons learned and future prospects
Amal A. El‐Moamly, Mohamed Aly El-Sweify
Tropical Medicine and Health (2023) Vol. 51, Iss. 1
Open Access | Times Cited: 46
Malaria prevention: from immunological concepts to effective vaccines and protective antibodies
Ian A. Cockburn, Robert A. Seder
Nature Immunology (2018) Vol. 19, Iss. 11, pp. 1199-1211
Open Access | Times Cited: 154
Clonal selection drives protective memory B cell responses in controlled human malaria infection
Rajagopal Murugan, Lisa Buchauer, Gianna Triller, et al.
Science Immunology (2018) Vol. 3, Iss. 20
Open Access | Times Cited: 145
Antibody Feedback Limits the Expansion of B Cell Responses to Malaria Vaccination but Drives Diversification of the Humoral Response
Hayley A. McNamara, Azza H. Idris, Henry J. Sutton, et al.
Cell Host & Microbe (2020) Vol. 28, Iss. 4, pp. 572-585.e7
Open Access | Times Cited: 137
Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults
Said Jongo, Seif Shekalaghe, L. W. Preston Church, et al.
American Journal of Tropical Medicine and Hygiene (2018) Vol. 99, Iss. 2, pp. 338-349
Open Access | Times Cited: 132
Controlled Human Malaria Infection: Applications, Advances, and Challenges
Danielle I. Stanisic, James McCarthy, Michael F. Good
Infection and Immunity (2017) Vol. 86, Iss. 1
Open Access | Times Cited: 129
A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver
Lawrence Wang, Lais S. Pereira, Yevel Flores-García, et al.
Immunity (2020) Vol. 53, Iss. 4, pp. 733-744.e8
Open Access | Times Cited: 123
Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity
Agnes Mwakingwe-Omari, Sara A. Healy, Jacquelyn Lane, et al.
Nature (2021) Vol. 595, Iss. 7866, pp. 289-294
Closed Access | Times Cited: 91
Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial
Martina Oneko, Laura C. Steinhardt, Reuben Yego, et al.
Nature Medicine (2021) Vol. 27, Iss. 9, pp. 1636-1645
Closed Access | Times Cited: 70
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial
Mahamadou S. Sissoko, Sara A. Healy, Abdoulaye Katilé, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 3, pp. 377-389
Open Access | Times Cited: 67
Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
Aroosa Younis Nadeem, Adeeb Shehzad, Salman Ul Islam, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 713-713
Open Access | Times Cited: 48
Malaria Vaccines: Progress to Date
Danielle I. Stanisic, Michael F. Good
BioDrugs (2023) Vol. 37, Iss. 6, pp. 737-756
Open Access | Times Cited: 34
Sporozoite immunization: innovative translational science to support the fight against malaria
Thomas L. Richie, L. W. Preston Church, Tooba Murshedkar, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 964-1007
Open Access | Times Cited: 27
A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion
Debashree Goswami, Hardik Patel, William Betz, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 4, pp. 723-754
Open Access | Times Cited: 15
Vaccines and monoclonal antibodies: new tools for malaria control
Kazutoyo Miura, Yevel Flores-García, Carole A. Long, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 11
Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite
Olivia A.C. Lamers, Blandine Franke‐Fayard, Jan Pieter R. Koopman, et al.
New England Journal of Medicine (2024) Vol. 391, Iss. 20, pp. 1913-1923
Closed Access | Times Cited: 10
Whole-genome sieve analysis: Identification of protective malaria antigens by leveraging allele-specific vaccine efficacy
Ryan J. Scalsky, Ankit Dwivedi, Thomas C. Stabler, et al.
Vaccine (2025) Vol. 50, pp. 126783-126783
Closed Access | Times Cited: 1
Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial
Jona Walk, Isaie J. Reuling, Marije C. Behet, et al.
BMC Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 79
Safety and Differential Antibody and T-Cell Responses to the Plasmodium falciparum Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants
Said Jongo, L. W. Preston Church, Ali Mtoro, et al.
American Journal of Tropical Medicine and Hygiene (2019) Vol. 100, Iss. 6, pp. 1433-1444
Open Access | Times Cited: 72
Page 1 - Next Page

Scroll to top